![](https://investorshub.advfn.com/uicon/842432.png?cb=1710370052)
Wednesday, May 01, 2024 3:16:03 PM
Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Share & Trends Analysis, By Drug Type (Stimulants, Non-stimulants), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy), By Demographics, By Region and Forecast Period 2023 – 2030 (Updated Version Available)
Report ID - MRC_3748 | Pages - 209 | Category - Healthcare and Pharma
“Key Players: Adlon Therapeutics L.P., Amnel Pharmaceuticals LLC., Aytu Biopharma Inc., American Brivision (Holding) , Corporation, Cingulate Inc., Eli Lilly And Company, GSK plc, Johnson & Johnson Services Inc., Neos Therapeutics Inc., Novartis AG, Noven Pharmaceuticals Inc, Otsuka Pharmaceutical Co. Ltd, Purdue Pharma L.P., RespireRx Pharmaceuticals Inc., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Tris Pharma Inc.”
https://marketresearchcommunity.com/attention-deficit-hyperactivity-disorder-adhd-market/?trk=article-ssr-frontend-pulse_little-text-block
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM